$0.84
-0.05 (-6.09%)
Open$0.87
Previous Close$0.89
Day High$0.95
Day Low$0.84
52W High$3.27
52W Low$0.64
Volume—
Avg Volume899.5K
Market Cap12.88M
P/E Ratio—
EPS$-2.07
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,555.5% upside
Current
$0.84
$0.84
Target
$22.24
$22.24
$15.33
$22.24 avg
$34.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.05M | 4.81M | 4.77M |
| Net Income | 16.59M | 633.7K | 796.1K |
| Profit Margin | 328.7% | 13.2% | 16.7% |
| EBITDA | -32,325,467 | 1.15M | 1.15M |
| Free Cash Flow | — | 870.8K | 772.5K |
| Rev Growth | +131.1% | +22.7% | +21.0% |
| Debt/Equity | — | 0.81 | 0.64 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |